Invex Therapeutics' (ASX: IXC) new partnership de-risks Presendin development (w/ Thomas Duthy)

Small Caps - A podcast by Small Caps

Invex Therapeutics (ASX: IXC) executive director Thomas Duthy joins Small Caps to discuss the company's new partnership with Korean...